-
1
-
-
69849101398
-
The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressiveness
-
Morote J, Ramirez C, Gomez E, et al,. The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressiveness. BJU Int 2009; 104: 486-9
-
(2009)
BJU Int
, vol.104
, pp. 486-489
-
-
Morote, J.1
Ramirez, C.2
Gomez, E.3
-
2
-
-
78449289245
-
Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: A nested case-control study
-
Sawada N, Iwasaki M, Inoue M, et al,. Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: a nested case-control study. Cancer Sci 2010; 101: 2652-7
-
(2010)
Cancer Sci
, vol.101
, pp. 2652-2657
-
-
Sawada, N.1
Iwasaki, M.2
Inoue, M.3
-
3
-
-
0023894263
-
Prediagnostic serum hormones and the risk of prostate cancer
-
Nomura A, Heilbrun LK, Stemmermann GN, Judd HL,. Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res 1988; 48: 3515-7
-
(1988)
Cancer Res
, vol.48
, pp. 3515-3517
-
-
Nomura, A.1
Heilbrun, L.K.2
Stemmermann, G.N.3
Judd, H.L.4
-
4
-
-
34447094139
-
-
9th edn. Wein A.J. Kavoussi L.R. Novick A.L. Partin A.W. Peters C.A. eds, Philadelphia: WB Saunders
-
Campbell MF, Wein AJ, Kavoussi LR,. Campbell-Walsh Urology, 9th edn., Wein AJ, Kavoussi LR, Novick AL, Partin AW, Peters CA, eds, Philadelphia: WB Saunders, 2007
-
(2007)
Campbell-Walsh Urology
-
-
Campbell, M.F.1
Wein, A.J.2
Kavoussi, L.R.3
-
5
-
-
79955459178
-
Low pretreatment total testosterone (<3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancer
-
Xylinas E, Ploussard G, Durand X, et al,. Low pretreatment total testosterone (<3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancer. BJU Int 2011; 107: 1400-3
-
(2011)
BJU Int
, vol.107
, pp. 1400-1403
-
-
Xylinas, E.1
Ploussard, G.2
Durand, X.3
-
6
-
-
27744467589
-
Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: Hypogonadism represents bad prognosis in prostate cancer
-
DOI 10.1097/01.ju.0000181818.51977.29
-
Teloken C, Da Ros CT, Caraver F, Weber FA, Cavalheiro AP, Graziottin TM,. Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer. J Urol 2005; 174: 2178-80 (Pubitemid 41611769)
-
(2005)
Journal of Urology
, vol.174
, Issue.6
, pp. 2178-2180
-
-
Teloken, C.1
Teodosio Da Ros, C.2
Caraver, F.3
Weber, F.A.4
Cavalheiro, A.P.5
Graziottin, T.M.6
-
7
-
-
34547156657
-
Preoperative Serum Testosterone Level as an Independent Predictor of Treatment Failure following Radical Prostatectomy
-
DOI 10.1016/j.eururo.2007.03.052, PII S0302283807004289
-
Yamamoto S, Yonese J, Kawakami S, et al,. Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. Eur Urol 2007; 52: 696-701 (Pubitemid 47126163)
-
(2007)
European Urology
, vol.52
, Issue.3
, pp. 696-701
-
-
Yamamoto, S.1
Yonese, J.2
Kawakami, S.3
Ohkubo, Y.4
Tatokoro, M.5
Komai, Y.6
Takeshita, H.7
Ishikawa, Y.8
Fukui, I.9
-
8
-
-
56449126893
-
Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy
-
Lane BR, Stephenson AJ, Magi-Galluzzi C, Lakin MM, Klein EA,. Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy. Urology 2008; 72: 1240-5
-
(2008)
Urology
, vol.72
, pp. 1240-1245
-
-
Lane, B.R.1
Stephenson, A.J.2
Magi-Galluzzi, C.3
Lakin, M.M.4
Klein, E.A.5
-
9
-
-
0015372799
-
Diurnal variation of plasma testosterone and cortisol
-
Rose RM, Kreuz LE, Holaday JW, Sulak KJ, Johnson CE,. Diurnal variation of plasma testosterone and cortisol. J Endocrinol 1972; 54: 177-8
-
(1972)
J Endocrinol
, vol.54
, pp. 177-178
-
-
Rose, R.M.1
Kreuz, L.E.2
Holaday, J.W.3
Sulak, K.J.4
Johnson, C.E.5
-
10
-
-
0015797193
-
Circadian rhythm of plasma testosterone, cortisol and gonadotropins in normal male subjects
-
Piro C, Fraioli F, Sciarra F, Conti C,. Circadian rhythm of plasma testosterone, cortisol and gonadotropins in normal male subjects. J Steroid Biochem 1973; 4: 321-9
-
(1973)
J Steroid Biochem
, vol.4
, pp. 321-329
-
-
Piro, C.1
Fraioli, F.2
Sciarra, F.3
Conti, C.4
-
11
-
-
39149084101
-
Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies
-
DOI 10.1093/jnci/djm323
-
Roddam AW, Allen NE, Appleby P, Key TJ,. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 2008; 100: 170-83 (Pubitemid 351480553)
-
(2008)
Journal of the National Cancer Institute
, vol.100
, Issue.3
, pp. 170-183
-
-
Roddam, A.W.1
Allen, N.E.2
Appleby, P.3
Key, T.J.4
-
12
-
-
18744369944
-
Testosterone as a predictor of pathological stage in clinically localized prostate cancer
-
DOI 10.1097/01.ju.0000158040.33531.e7
-
Isom-Batz G, Bianco FJ Jr, Kattan MW, Mulhall JP, Lilja H, Eastham JA,. Testosterone as a predictor of pathological stage in clinically localized prostate cancer. J Urol 2005; 173: 1935-7 (Pubitemid 40675215)
-
(2005)
Journal of Urology
, vol.173
, Issue.6
, pp. 1935-1937
-
-
Isom-Batz, G.1
Blanco Jr., F.J.2
Kattan, M.W.3
Mulhall, J.P.4
Lilja, H.5
Eastham, J.A.6
-
13
-
-
0344406150
-
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy
-
DOI 10.1097/01.ju.0000062674.43964.d0
-
Massengill JC, Sun L, Moul JW, et al,. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol 2003; 169: 1670-5 (Pubitemid 36443468)
-
(2003)
Journal of Urology
, vol.169
, Issue.5
, pp. 1670-1675
-
-
Massengill, J.C.1
Sun, L.2
Moul, J.W.3
Wu, H.4
McLeod, D.G.5
Amling, C.6
Lance, R.7
Foley, J.8
Sexton, W.9
Kusuda, L.10
Chung, A.11
Soderdahl, D.12
Donahue, T.13
-
14
-
-
0032324294
-
Influence of radical prostatectomy on serum hormone levels
-
DOI 10.1016/S0022-5347(01)62922-7
-
Miller LR, Partin AW, Chan DW, et al,. Influence of radical prostatectomy on serum hormone levels. J Urol 1998; 160: 449-53 (Pubitemid 29476696)
-
(1998)
Journal of Urology
, vol.160
, Issue.2
, pp. 449-453
-
-
Miller, L.R.1
Partin, A.W.2
Chan, D.W.3
Bruzek, D.J.4
Dobs, A.S.5
Epstein, J.I.6
Walsh, P.C.7
-
15
-
-
0032038146
-
Recent progress in our understanding of inhibin in the prostate gland
-
Risbridger GP,. Recent progress in our understanding of inhibin in the prostate gland. J Endocrinol 1998; 157: 1-4
-
(1998)
J Endocrinol
, vol.157
, pp. 1-4
-
-
Risbridger, G.P.1
-
16
-
-
60349097318
-
Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients?
-
Imamoto T, Suzuki H, Yano M, et al,. Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients? Prostate Cancer Prostatic Dis 2009; 12: 78-82
-
(2009)
Prostate Cancer Prostatic Dis
, vol.12
, pp. 78-82
-
-
Imamoto, T.1
Suzuki, H.2
Yano, M.3
-
17
-
-
0018975785
-
Total and SHBG-bound testosterone and 5α-dihydrotestosterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma
-
Lukkarinen O,. Total and SHBG-bound testosterone and 5 alpha-dihydrotestosterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma. Br J Urol 1980; 52: 377-80 (Pubitemid 10010928)
-
(1980)
British Journal of Urology
, vol.52
, Issue.5
, pp. 377-380
-
-
Lukkarinen, O.1
-
18
-
-
0037377311
-
Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer
-
DOI 10.1097/01.ju.0000056900.26628.16
-
Schatzl G, Madersbacher S, Haitel A, et al,. Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer. J Urol 2003; 169: 1312-5 (Pubitemid 36323774)
-
(2003)
Journal of Urology
, vol.169
, Issue.4
, pp. 1312-1315
-
-
Schatzl, G.1
Madersbacher, S.2
Haitel, A.3
Gsur, A.4
Preyer, M.5
Haidinger, G.6
Gassner, C.7
Ochsner, M.8
Marberger, M.9
-
19
-
-
0035313592
-
High-grade prostate cancer is associated with low serum testosterone levels
-
DOI 10.1002/pros.1046
-
Schatzl G, Madersbacher S, Thurridl T, et al,. High-grade prostate cancer is associated with low serum testosterone levels. Prostate 2001; 47: 52-8 (Pubitemid 32246752)
-
(2001)
Prostate
, vol.47
, Issue.1
, pp. 52-58
-
-
Schatzl, G.1
Madersbacher, S.2
Thurridl, T.3
Waldmuller, J.4
Kramer, G.5
Haitel, A.6
Marberger, M.7
-
20
-
-
0343048346
-
Endocrine status in elderly men with lower urinary tract symptoms: Correlation of age, hormonal status, and lower urinary tract function
-
DOI 10.1016/S0090-4295(99)00473-2, PII S0090429599004732
-
Schatzl G, Brossner C, Schmid S, et al,. Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology. Urology 2000; 55: 397-402 (Pubitemid 30110593)
-
(2000)
Urology
, vol.55
, Issue.3
, pp. 397-402
-
-
Schatzl, G.1
Brossner, C.2
Schmid, S.3
Kugler, W.4
Roehrich, M.5
Treu, T.6
Szalay, A.7
Djavan, B.8
Schmidbauer, C.P.9
Soregi, S.10
Madersbacher, S.11
-
21
-
-
0033950926
-
Is low serum free testosterone a marker for high grade prostate cancer?
-
Hoffman MA, DeWolf WC, Morgentaler A,. Is low serum free testosterone a marker for high grade prostate cancer? J Urol 2000; 163: 824-7 (Pubitemid 30091624)
-
(2000)
Journal of Urology
, vol.163
, Issue.3
, pp. 824-827
-
-
Hoffman, M.A.1
DeWolf, W.C.2
Morgentaler, A.3
-
22
-
-
33744948333
-
Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline
-
DOI 10.1210/jc.2005-2847
-
Bhasin S, Cunningham GR, Hayes FJ, et al,. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91: 1995-2010 (Pubitemid 43854972)
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, Issue.6
, pp. 1995-2010
-
-
Bhasin, S.1
Cunningham, G.R.2
Hayes, F.J.3
Matsumoto, A.M.4
Snyder, P.J.5
Swerdloff, R.S.6
Montori, V.M.7
-
23
-
-
0025884064
-
Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study
-
Gray A, Feldman HA, McKinlay JB, Longcope C,. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991; 73: 1016-25 (Pubitemid 21901140)
-
(1991)
Journal of Clinical Endocrinology and Metabolism
, vol.73
, Issue.5
, pp. 1016-1025
-
-
Gray, A.1
Feldman, H.A.2
McKinlay, J.B.3
Longcope, C.4
-
24
-
-
33646945083
-
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
-
DOI 10.1093/jnci/djj190
-
Stephenson AJ, Scardino PT, Eastham JA, et al,. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 2006; 98: 715-7 (Pubitemid 43821789)
-
(2006)
Journal of the National Cancer Institute
, vol.98
, Issue.10
, pp. 715-717
-
-
Stephenson, A.J.1
Scardino, P.T.2
Eastham, J.A.3
Bianco Jr., F.J.4
Dotan, Z.A.5
Fearn, P.A.6
Kattan, M.W.7
-
25
-
-
33751010199
-
Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy
-
DOI 10.1002/cncr.22262
-
Cooperberg MR, Freedland SJ, Pasta DJ, et al,. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer 2006; 107: 2384-91 (Pubitemid 44748521)
-
(2006)
Cancer
, vol.107
, Issue.10
, pp. 2384-2391
-
-
Cooperberg, M.R.1
Freedland, S.J.2
Pasta, D.J.3
Elkin, E.P.4
Presti, J.C.5
Amling, C.L.6
Terris, M.K.7
Aronson, W.J.8
Kane, C.J.9
Carroll, P.R.10
-
26
-
-
0029016831
-
Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: Interim results of a prospective randomized trial. The Belgian Uro-Oncological Study Group
-
Van Poppel H, De Ridder D, Elgamal AA, et al,. Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial. The Belgian Uro-Oncological Study Group. J Urol 1995; 154: 429-34
-
(1995)
J Urol
, vol.154
, pp. 429-434
-
-
Van Poppel, H.1
De Ridder, D.2
Elgamal, A.A.3
-
27
-
-
0036828025
-
Pathologic effects of neoadjuvant cyproterone acetate on nonneoplastic prostate, prostatic intraepithelial neoplasia, and adenocarcinoma: A detailed analysis of radical prostatectomy specimens from a randomized trial
-
DOI 10.1097/00000478-200211000-00002
-
Bullock MJ, Srigley JR, Klotz LH, Goldenberg SL,. Pathologic effects of neoadjuvant cyproterone acetate on nonneoplastic prostate, prostatic intraepithelial neoplasia, and adenocarcinoma: a detailed analysis of radical prostatectomy specimens from a randomized trial. Am J Surg Pathol 2002; 26: 1400-13 (Pubitemid 35239416)
-
(2002)
American Journal of Surgical Pathology
, vol.26
, Issue.11
, pp. 1400-1413
-
-
Bullock, M.J.1
Srigley, J.R.2
Klotz, L.H.3
Larry Goldenberg, S.4
-
28
-
-
0036381078
-
Three-month neoadjuvant hormonal therapy before radical prostatectomy: A 7-year follow-up of a randomized controlled trial
-
Aus G, Abrahamsson PA, Ahlgren G, et al,. Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial. BJU Int 2002; 90: 561-6
-
(2002)
BJU Int
, vol.90
, pp. 561-566
-
-
Aus, G.1
Abrahamsson, P.A.2
Ahlgren, G.3
|